Logo image of AGAIN.MI

CLOUDIA RESEARCH SPA (AGAIN.MI) Stock Fundamental Analysis

BIT:AGAIN - Euronext Milan - IT0005577090 - Common Stock - Currency: EUR

1.85  0 (0%)

Fundamental Rating

5

Overall AGAIN gets a fundamental rating of 5 out of 10. We evaluated AGAIN against 78 industry peers in the IT Services industry. AGAIN has an average financial health and profitability rating. AGAIN is not priced too expensively while it is growing strongly. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

AGAIN had positive earnings in the past year.
AGAIN had a positive operating cash flow in the past year.
AGAIN.MI Yearly Net Income VS EBIT VS OCF VS FCFAGAIN.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 1M -1M

1.2 Ratios

AGAIN's Return On Assets of 5.80% is fine compared to the rest of the industry. AGAIN outperforms 69.23% of its industry peers.
With a Return On Equity value of 10.66%, AGAIN perfoms like the industry average, outperforming 46.15% of the companies in the same industry.
With a Return On Invested Capital value of 4.34%, AGAIN is not doing good in the industry: 64.10% of the companies in the same industry are doing better.
The Average Return On Invested Capital over the past 3 years for AGAIN is above the industry average of 11.17%.
The last Return On Invested Capital (4.34%) for AGAIN is well below the 3 year average (13.42%), which needs to be investigated, but indicates that AGAIN had better years and this may not be a problem.
Industry RankSector Rank
ROA 5.8%
ROE 10.66%
ROIC 4.34%
ROA(3y)9.28%
ROA(5y)N/A
ROE(3y)28.64%
ROE(5y)N/A
ROIC(3y)13.42%
ROIC(5y)N/A
AGAIN.MI Yearly ROA, ROE, ROICAGAIN.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 10 20 30 40 50

1.3 Margins

With an excellent Profit Margin value of 8.19%, AGAIN belongs to the best of the industry, outperforming 84.62% of the companies in the same industry.
In the last couple of years the Profit Margin of AGAIN has grown nicely.
Looking at the Operating Margin, with a value of 5.88%, AGAIN is in line with its industry, outperforming 50.00% of the companies in the same industry.
In the last couple of years the Operating Margin of AGAIN has declined.
Looking at the Gross Margin, with a value of 71.04%, AGAIN is in the better half of the industry, outperforming 64.10% of the companies in the same industry.
AGAIN's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 5.88%
PM (TTM) 8.19%
GM 71.04%
OM growth 3Y-2.97%
OM growth 5YN/A
PM growth 3Y16.29%
PM growth 5YN/A
GM growth 3Y-4.58%
GM growth 5YN/A
AGAIN.MI Yearly Profit, Operating, Gross MarginsAGAIN.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 20 40 60 80

More info and screens

5

2. Health

2.1 Basic Checks

AGAIN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, AGAIN has more shares outstanding
Compared to 1 year ago, AGAIN has an improved debt to assets ratio.
AGAIN.MI Yearly Shares OutstandingAGAIN.MI Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 1M 2M 3M 4M 5M
AGAIN.MI Yearly Total Debt VS Total AssetsAGAIN.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2M 4M 6M 8M

2.2 Solvency

AGAIN has an Altman-Z score of 2.64. This is not the best score and indicates that AGAIN is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of AGAIN (2.64) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.22 indicates that AGAIN is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.22, AGAIN is doing good in the industry, outperforming 69.23% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Altman-Z 2.64
ROIC/WACC0.57
WACC7.67%
AGAIN.MI Yearly LT Debt VS Equity VS FCFAGAIN.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 2M 4M

2.3 Liquidity

A Current Ratio of 1.90 indicates that AGAIN should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.90, AGAIN belongs to the top of the industry, outperforming 88.46% of the companies in the same industry.
A Quick Ratio of 1.90 indicates that AGAIN should not have too much problems paying its short term obligations.
The Quick ratio of AGAIN (1.90) is better than 89.74% of its industry peers.
Industry RankSector Rank
Current Ratio 1.9
Quick Ratio 1.9
AGAIN.MI Yearly Current Assets VS Current LiabilitesAGAIN.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 1M 2M 3M 4M 5M

More info and screens

7

3. Growth

3.1 Past

AGAIN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -27.26%.
Measured over the past years, AGAIN shows a very strong growth in Earnings Per Share. The EPS has been growing by 57.26% on average per year.
Looking at the last year, AGAIN shows a quite strong growth in Revenue. The Revenue has grown by 13.21% in the last year.
Measured over the past years, AGAIN shows a very strong growth in Revenue. The Revenue has been growing by 45.87% on average per year.
EPS 1Y (TTM)-27.26%
EPS 3Y57.26%
EPS 5YN/A
EPS Q2Q%-61.99%
Revenue 1Y (TTM)13.21%
Revenue growth 3Y45.87%
Revenue growth 5YN/A
Sales Q2Q%20.21%

3.2 Future

The Earnings Per Share is expected to grow by 29.07% on average over the next years. This is a very strong growth
Based on estimates for the next years, AGAIN will show a quite strong growth in Revenue. The Revenue will grow by 18.22% on average per year.
EPS Next Y60.03%
EPS Next 2Y44.92%
EPS Next 3Y27.23%
EPS Next 5Y29.07%
Revenue Next Year32.26%
Revenue Next 2Y19.14%
Revenue Next 3Y17.36%
Revenue Next 5Y18.22%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
AGAIN.MI Yearly Revenue VS EstimatesAGAIN.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 5M 10M 15M
AGAIN.MI Yearly EPS VS EstimatesAGAIN.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 0.1 0.2 0.3 0.4 0.5

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 15.42, which indicates a correct valuation of AGAIN.
Based on the Price/Earnings ratio, AGAIN is valued a bit cheaper than 73.08% of the companies in the same industry.
When comparing the Price/Earnings ratio of AGAIN to the average of the S&P500 Index (26.52), we can say AGAIN is valued slightly cheaper.
The Price/Forward Earnings ratio is 5.66, which indicates a rather cheap valuation of AGAIN.
Based on the Price/Forward Earnings ratio, AGAIN is valued cheaply inside the industry as 97.44% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 22.25. AGAIN is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 15.42
Fwd PE 5.66
AGAIN.MI Price Earnings VS Forward Price EarningsAGAIN.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AGAIN is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.12
AGAIN.MI Per share dataAGAIN.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

AGAIN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as AGAIN's earnings are expected to grow with 27.23% in the coming years.
PEG (NY)0.26
PEG (5Y)N/A
EPS Next 2Y44.92%
EPS Next 3Y27.23%

More info and screens

0

5. Dividend

5.1 Amount

AGAIN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CLOUDIA RESEARCH SPA

BIT:AGAIN (6/3/2025, 7:00:00 PM)

1.85

0 (0%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners16.36%
Inst Owner ChangeN/A
Ins Owners41.05%
Ins Owner ChangeN/A
Market Cap9.64M
Analysts84.44
Price Target5.5 (197.3%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 15.42
Fwd PE 5.66
P/S 1.41
P/FCF N/A
P/OCF 17.47
P/B 1.83
P/tB 3.18
EV/EBITDA 9.12
EPS(TTM)0.12
EY6.49%
EPS(NY)0.33
Fwd EY17.68%
FCF(TTM)-0.29
FCFYN/A
OCF(TTM)0.11
OCFY5.72%
SpS1.32
BVpS1.01
TBVpS0.58
PEG (NY)0.26
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.8%
ROE 10.66%
ROCE 5.79%
ROIC 4.34%
ROICexc 5.26%
ROICexgc 8.62%
OM 5.88%
PM (TTM) 8.19%
GM 71.04%
FCFM N/A
ROA(3y)9.28%
ROA(5y)N/A
ROE(3y)28.64%
ROE(5y)N/A
ROIC(3y)13.42%
ROIC(5y)N/A
ROICexc(3y)16.46%
ROICexc(5y)N/A
ROICexgc(3y)20.34%
ROICexgc(5y)N/A
ROCE(3y)17.89%
ROCE(5y)N/A
ROICexcg growth 3Y-5.56%
ROICexcg growth 5YN/A
ROICexc growth 3Y-19.06%
ROICexc growth 5YN/A
OM growth 3Y-2.97%
OM growth 5YN/A
PM growth 3Y16.29%
PM growth 5YN/A
GM growth 3Y-4.58%
GM growth 5YN/A
F-Score4
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Debt/EBITDA 1.06
Cap/Depr 298.29%
Cap/Sales 30%
Interest Coverage 250
Cash Conversion 50.47%
Profit Quality N/A
Current Ratio 1.9
Quick Ratio 1.9
Altman-Z 2.64
F-Score4
WACC7.67%
ROIC/WACC0.57
Cap/Depr(3y)372.34%
Cap/Depr(5y)N/A
Cap/Sales(3y)28.85%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-27.26%
EPS 3Y57.26%
EPS 5YN/A
EPS Q2Q%-61.99%
EPS Next Y60.03%
EPS Next 2Y44.92%
EPS Next 3Y27.23%
EPS Next 5Y29.07%
Revenue 1Y (TTM)13.21%
Revenue growth 3Y45.87%
Revenue growth 5YN/A
Sales Q2Q%20.21%
Revenue Next Year32.26%
Revenue Next 2Y19.14%
Revenue Next 3Y17.36%
Revenue Next 5Y18.22%
EBIT growth 1Y-47.46%
EBIT growth 3Y41.54%
EBIT growth 5YN/A
EBIT Next Year108.4%
EBIT Next 3Y44.28%
EBIT Next 5Y39.48%
FCF growth 1Y10.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-59.03%
OCF growth 3YN/A
OCF growth 5YN/A